LATAM Bif Registry Has Enrolled Over 700 Patients

After a year of hard work, LATAM Bif-SOLACI has included over 700 patients! From SOLACI Research and the Registry Board of Directors we are glad to lead this important research initiative and we hope to keep growing in the coming months and be able to contribute with reliable data that will allow us to perfect the clinical practice across Latin America. 

To join LATAM Bif Registry, follow this link:

What is LATAM Bif Registry?

LATAM BIF Registry is a group of Latin American interventional cardiologists committed to fostering continuous medical education, research, and scientific exchange, dedicated to promoting the correct techniques, and focused on the treatment of coronary artery bifurcation lesions.   

LATAM BIF Board of Directors

LATAM Bif Collaborators Committee

Objectives

  • Incorporating useful new technologies for the percutaneous intervention of these complex lesions in the region. 
  • Promoting continuous medical education in the treatment of coronary artery bifurcation lesions in LATAM.
  • Assessing the current situation and the needs in LATAM and generating the strategies for improvement. 
  • Scientifically interacting with the world’s leading societies in the treatment of coronary artery bifurcations.
  • Organizing interactive meetings and webinars to improve knowledge and technical abilities in the field. 
    •  

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SOLACI Wishes You Happy Holidays

From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....